Skip to main content

IDWeek 2018

Health-Related Social Vulnerabilities in a Pediatric Outpatient Antimicrobial Therapy Program

The AMMO Study: Antimicrobial Management in Extracorporeal Membrane Oxygenation

Systematic Review and Network Meta-Analysis of Randomized Trials of Antibiotic Therapy for Community-Acquired Pneumonia

LEAP 2 Study Shows Oral Lefamulin Is Safe and Effective in Treatment of Adults with Community-Acquired Bacterial Pneumonia

Pooled Analysis of Safety Data from Phase 2 and 3 Clinical Trials Evaluating Eravacycline in Complicated Intra-Abdominal Infections

Integrated Safety Summary of Omadacycline, A Novel Aminomethylcycline Antibiotic

Antimicrobial Stewardship Program Aims to Reduce Antimicrobial Usage in Geriatric Patients without Affecting Outcomes

Longer Duration of Antibiotic Therapy for Community-Acquired Pneumonia and Risk for Clostridium Difficile Infection

New Robust Antimicrobial Stewardship Program Results in Reduction of Clostridium Difficile 30-Day Readmission

FDA Approves NUZYRA™ (Omadacycline) for Community-Acquired Bacterial Pneumonia and Acute Skin and Skin Structure Infections

Page 1 of 3
Results 1 - 10 of 23